...
首页> 外文期刊>Frontiers in Bioengineering and Biotechnology >CLING: Candidate Cancer-Related lncRNA Prioritization via Integrating Multiple Biological Networks
【24h】

CLING: Candidate Cancer-Related lncRNA Prioritization via Integrating Multiple Biological Networks

机译:Cling:候选癌症相关的LNCRNA优先级通过整合多个生物网络

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Identification and characterization of lncRNAs in cancer with a view to their application in improving diagnosis and therapy remains a major challenge that requires new and innovative approaches. We have developed an integrative framework termed 'CLING', aimed to prioritize candidate cancer-related lncRNAs based on their associations with known cancer lncRNAs. CLING focuses on joint optimization and prioritization of all candidates for each cancer type by integrating lncRNA topological properties and multiple lncRNA-centric networks. Validation analyses revealed that CLING is more effective than prioritization based on a single lncRNA network. Reliable AUC scores were obtained across 10 cancer types, ranging from 0.85 to 0.94. Several novel lncRNAs predicted in the top 10 candidates for various cancer types have been confirmed by recent biological experiments. Furthermore, using a case study on liver hepatocellular carcinoma as an example, CLING facilitated the successful identification of novel cancer lncRNAs overlooked by differential expression analyses. This time- and cost-effective computational model may provide a valuable complement to experimental studies and assist with future investigations on lncRNA involvement in the pathogenesis of cancers. We have developed a web-based server for users to rapidly implement CLING and visualize data, which is freely accessible at http://bio-bigdata.hrbmu.edu.cn/cling/. CLING has been successfully applied to predict a few potential lncRNAs from thousands of candidates for many cancer types.
机译:癌症中LNCRNA的鉴定与表征,以其在改善诊断和治疗方面的应用仍然是需要新的和创新方法的主要挑战。我们制定了一个被称为“紧身”的综合框架,旨在根据与已知癌症LNCRNA的关联优先考虑候选癌症相关的LNCRNA。通过整合LNCRNA拓扑特性和多次LNCRNA为中心的网络,CLing侧重于各种癌症类型的所有候选者的联合优化和优先级。验证分析显示,基于单个LNCRNA网络的优先级,粘附更有效。在10种癌症类型中获得可靠的AUC评分,范围为0.85至0.94。最近的生物实验证实了几种用于各种癌症类型候选人的几种新的LNCRNA。此外,利用肝肝细胞癌的案例研究作为一个例子,施用促进了通过差异表达分析忽略俯视的新型癌症LNCRNA的成功鉴定。这种时间和经济效益的计算模型可以提供对实验研究的有价值的补充,并协助将来对LNCRNA涉及癌症发病机制的未来调查。我们开发了一个基于Web的服务器,供用户快速实现CLING和可视化数据,可在http://bio-bigdata.hrbmu.edu.cn/cling/上自由访问。固定已成功地应用于预测来自数千名候选人的一些潜在的LNCRNA,用于许多癌症类型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号